148 related articles for article (PubMed ID: 12505254)
1. Characterization of chromosomal aberrations in a case of glioblastoma multiforme combining cytogenetic and molecular cytogenetic techniques.
Zuber MA; Krupp W; Holland H; Froster UG
Cancer Genet Cytogenet; 2002 Oct; 138(2):111-5. PubMed ID: 12505254
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic and molecular cytogenetic analyses in diffuse astrocytomas.
Krupp W; Geiger K; Schober R; Siegert G; Froster UG
Cancer Genet Cytogenet; 2004 Aug; 153(1):32-8. PubMed ID: 15325091
[TBL] [Abstract][Full Text] [Related]
3. A recurrent 19q11-12 breakpoint suggested by cytogenetic and fluorescence in situ hybridization analysis of three glioblastoma cell lines.
Magnani I; Chiariello E; Conti AM; Finocchiaro G
Cancer Genet Cytogenet; 1999 Apr; 110(2):82-6. PubMed ID: 10214354
[TBL] [Abstract][Full Text] [Related]
4. Hidden aberrations diagnosed by interphase fluorescence in situ hybridisation and spectral karyotyping in childhood acute lymphoblastic leukaemia.
Nordgren A
Leuk Lymphoma; 2003 Dec; 44(12):2039-53. PubMed ID: 14959846
[TBL] [Abstract][Full Text] [Related]
5. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization.
Naus NC; van Drunen E; de Klein A; Luyten GP; Paridaens DA; Alers JC; Ksander BR; Beverloo HB; Slater RM
Genes Chromosomes Cancer; 2001 Mar; 30(3):267-73. PubMed ID: 11170284
[TBL] [Abstract][Full Text] [Related]
6. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
[TBL] [Abstract][Full Text] [Related]
7. Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2.
Hilgenfeld E; Padilla-Nash H; McNeil N; Knutsen T; Montagna C; Tchinda J; Horst J; Ludwig WD; Serve H; Büchner T; Berdel WE; Schröck E; Ried T
Br J Haematol; 2001 May; 113(2):305-17. PubMed ID: 11380393
[TBL] [Abstract][Full Text] [Related]
8. Spectral karyotyping study of chromosome abnormalities in human leukemia.
Zhao L; Hayes K; Khan Z; Glassman A
Cancer Genet Cytogenet; 2001 Jun; 127(2):143-7. PubMed ID: 11425454
[TBL] [Abstract][Full Text] [Related]
9. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.
Kakazu N; Taniwaki M; Horiike S; Nishida K; Tatekawa T; Nagai M; Takahashi T; Akaogi T; Inazawa J; Ohki M; Abe T
Genes Chromosomes Cancer; 1999 Dec; 26(4):336-45. PubMed ID: 10534769
[TBL] [Abstract][Full Text] [Related]
10. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping.
Veldman T; Vignon C; Schröck E; Rowley JD; Ried T
Nat Genet; 1997 Apr; 15(4):406-10. PubMed ID: 9090389
[TBL] [Abstract][Full Text] [Related]
11. Identification of recurrent chromosomal rearrangements and the unique relationship between low-level amplification and translocation in glioblastoma.
Kubota H; Nishizaki T; Harada K; Harada K; Oga A; Ito H; Suzuki M; Sasaki K
Genes Chromosomes Cancer; 2001 Jun; 31(2):125-33. PubMed ID: 11319800
[TBL] [Abstract][Full Text] [Related]
12. Molecular cytogenetic analysis of the bladder carcinoma cell line BK-10 by spectral karyotyping.
Padilla-Nash HM; Nash WG; Padilla GM; Roberson KM; Robertson CN; Macville M; Schröck E; Ried T
Genes Chromosomes Cancer; 1999 May; 25(1):53-9. PubMed ID: 10221340
[TBL] [Abstract][Full Text] [Related]
13. Molecular and cytogenetic analysis of glioblastoma multiforme.
Mao X; Hamoudi RA
Cancer Genet Cytogenet; 2000 Oct; 122(2):87-92. PubMed ID: 11106817
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft.
Aldosari N; Wiltshire RN; Dutra A; Schrock E; McLendon RE; Friedman HS; Bigner DD; Bigner SH
Neuro Oncol; 2002 Apr; 4(2):75-85. PubMed ID: 11916498
[TBL] [Abstract][Full Text] [Related]
15. Complete cytogenetic characterization of the human breast cancer cell line MA11 combining G-banding, comparative genomic hybridization, multicolor fluorescence in situ hybridization, RxFISH, and chromosome-specific painting.
Micci F; Teixeira MR; Heim S
Cancer Genet Cytogenet; 2001 Nov; 131(1):25-30. PubMed ID: 11734314
[TBL] [Abstract][Full Text] [Related]
16. Integration of global spectral karyotyping, CGH arrays, and expression arrays reveals important genes in the pathogenesis of glioblastoma multiforme.
Leone PE; González MB; Elosua C; Gómez-Moreta JA; Lumbreras E; Robledo C; Santos-Briz A; Valero JM; de la Guardia RD; Gutiérrez NC; Hernández JM; García JL
Ann Surg Oncol; 2012 Jul; 19(7):2367-79. PubMed ID: 22395973
[TBL] [Abstract][Full Text] [Related]
17. Screening of genomic imbalances in glioblastoma multiforme using high-resolution comparative genomic hybridization.
Vranová V; Necesalová E; Kuglík P; Cejpek P; Pesáková M; Budínská E; Relichová J; Veselská R
Oncol Rep; 2007 Feb; 17(2):457-64. PubMed ID: 17203188
[TBL] [Abstract][Full Text] [Related]
18. Genomic aberrations in 80 cases of primary glioblastoma multiforme: Pathogenetic heterogeneity and putative cytogenetic pathways.
Dahlback HS; Brandal P; Meling TR; Gorunova L; Scheie D; Heim S
Genes Chromosomes Cancer; 2009 Oct; 48(10):908-24. PubMed ID: 19603525
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines.
Harris CP; Lu XY; Narayan G; Singh B; Murty VV; Rao PH
Genes Chromosomes Cancer; 2003 Mar; 36(3):233-41. PubMed ID: 12557223
[TBL] [Abstract][Full Text] [Related]
20. Assessment of molecular cytogenetic methods for the detection of chromosomal abnormalities.
Une T; Yokoyama Y; Ninomiya S; Shinozuka M; Maruyama H; Morishima T
Acta Med Okayama; 2006 Oct; 60(5):279-87. PubMed ID: 17072374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
